CD274 and non-small cell lung carcinoma: However, a recent study showed that 44–50% of NSCLC patients with high PD-L1 expression or high TMB did not respond to ICB while 12–15% of patients with low PD-L1 expression or low TMB achieved a partial or complete response [11].